Casi pharmaceuticals announces cnct19 (cd19 car-t) receives china breakthrough therapy designation

Rockville, md., and beijing, dec. 23, 2020 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that the chinese center for drug...
CASI Ratings Summary
CASI Quant Ranking